Nodular hyperplasia of the prostate gland - Revision history

Michael: create

2024-04-24T20:42:10Z

create

← Older revision		Revision as of 20:42, 24 April 2024
Line 28:		Line 28:
	\| Other =		\| Other =
	\| ClinDDx = other causes of hematuria ([[urothelial carcinoma]], [[renal cell carcinoma]], cystitis), other causes of obstruction ([[prostate carcinoma]], [[urothelial carcinoma]])		\| ClinDDx = other causes of hematuria ([[urothelial carcinoma]], [[renal cell carcinoma]], cystitis), other causes of obstruction ([[prostate carcinoma]], [[urothelial carcinoma]])
	\| Tx = medical, [[TURP]]		\| Tx = medical, [[TURP]], others
	}}		}}
	'''Nodular hyperplasia of the prostate gland''', also '''benign prostatic hyperplasia''' (abbreviated '''BPH'''), is a common benign pathology of the [[prostate gland]].		'''Nodular hyperplasia of the prostate gland''', also '''benign prostatic hyperplasia''' (abbreviated '''BPH'''), is a common benign pathology of the [[prostate gland]].
Line 55:		Line 55:
	*Transurethral resection of the prostate (TURP).		*Transurethral resection of the prostate (TURP).
	*[[Rezum]].<ref>{{cite journal \|authors=Westwood J, Geraghty R, Jones P, Rai BP, Somani BK \|title=Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia \|journal=Ther Adv Urol \|volume=10 \|issue=11 \|pages=327–333 \|date=November 2018 \|pmid=30344644 \|pmc=6180381 \|doi=10.1177/1756287218793084 \|url=}}</ref>		*[[Rezum]].<ref>{{cite journal \|authors=Westwood J, Geraghty R, Jones P, Rai BP, Somani BK \|title=Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia \|journal=Ther Adv Urol \|volume=10 \|issue=11 \|pages=327–333 \|date=November 2018 \|pmid=30344644 \|pmc=6180381 \|doi=10.1177/1756287218793084 \|url=}}</ref>
			*Laser treatment ([[GreenLight]]).<ref name=pmid31617419>{{cite journal \|authors=Campobasso D, Marchioni M, Altieri V, Greco F, De Nunzio C, Destefanis P, Ricciardulli S, Bergamaschi F, Fasolis G, Varvello F, Voce S, Palmieri F, Divan C, Malossini G, Oriti R, Tuccio A, Ruggera L, Tubaro A, Delicato G, Laganà A, Dadone C, De Rienzo G, Frattini A, Pucci L, Carrino M, Montefiore F, Germani S, Miano R, Schips L, Rabito S, Ferrari G, Cindolo L \|title=GreenLight Photoselective Vaporization of the Prostate: One Laser for Different Prostate Sizes \|journal=J Endourol \|volume=34 \|issue=1 \|pages=54–62 \|date=January 2020 \|pmid=31617419 \|doi=10.1089/end.2019.0478 \|url=}}</ref>

	==Gross==		==Gross==

Michael at 15:21, 20 October 2023

2023-10-20T15:21:51Z

← Older revision		Revision as of 15:21, 20 October 2023
Line 83:		Line 83:
	<pre>		<pre>
	Prostate Tissue, Transurethral Resection of Prostate (TURP):		Prostate Tissue, Transurethral Resection of Prostate (TURP):
	- Benign prostatic tissue with glandular and stromal proliferation.		- Benign prostatic tissue with glandular and stromal proliferation.
	- Benign urothelial mucosa with inflammation.		- Benign urothelial mucosa with inflammation.
	- NEGATIVE for malignancy.		- NEGATIVE for malignancy.
	</pre>		</pre>

Michael at 16:59, 17 November 2022

2022-11-17T16:59:44Z

← Older revision		Revision as of 16:59, 17 November 2022
Line 54:		Line 54:
	*Medications.		*Medications.
	*Transurethral resection of the prostate (TURP).		*Transurethral resection of the prostate (TURP).
			*[[Rezum]].<ref>{{cite journal \|authors=Westwood J, Geraghty R, Jones P, Rai BP, Somani BK \|title=Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia \|journal=Ther Adv Urol \|volume=10 \|issue=11 \|pages=327–333 \|date=November 2018 \|pmid=30344644 \|pmc=6180381 \|doi=10.1177/1756287218793084 \|url=}}</ref>

	==Gross==		==Gross==

Michael: /* Microscopic */ tweak

2022-01-03T16:15:23Z

Microscopic: tweak

← Older revision		Revision as of 16:15, 3 January 2022
Line 71:		Line 71:
	*[[Urothelial carcinoma]] - significant nuclear atypia.		*[[Urothelial carcinoma]] - significant nuclear atypia.
	*[[Prostate carcinoma]] - especially low-grade.		*[[Prostate carcinoma]] - especially low-grade.
	*[[~~Smooth muscle~~ tumour of uncertain malignant potential]] - lacks small vessels.<ref name=pmid17170745>{{Cite journal \| last1 = Hansel \| first1 = DE. \| last2 = Herawi \| first2 = M. \| last3 = Montgomery \| first3 = E. \| last4 = Epstein \| first4 = JI. \| title = Spindle cell lesions of the adult prostate. \| journal = Mod Pathol \| volume = 20 \| issue = 1 \| pages = 148-58 \| month = Jan \| year = 2007 \| doi = 10.1038/modpathol.3800676 \| PMID = 17170745 }}</ref>		*[[Prostatic stromal tumour of uncertain malignant potential]] - lacks small vessels.<ref name=pmid17170745>{{Cite journal \| last1 = Hansel \| first1 = DE. \| last2 = Herawi \| first2 = M. \| last3 = Montgomery \| first3 = E. \| last4 = Epstein \| first4 = JI. \| title = Spindle cell lesions of the adult prostate. \| journal = Mod Pathol \| volume = 20 \| issue = 1 \| pages = 148-58 \| month = Jan \| year = 2007 \| doi = 10.1038/modpathol.3800676 \| PMID = 17170745 }}</ref>

	===Images===		===Images===

Michael: /* Urothelium present */

2015-08-21T16:56:41Z

Urothelium present

← Older revision		Revision as of 16:56, 21 August 2015
Line 84:		Line 84:
	- Benign prostatic tissue with glandular and stromal proliferation.		- Benign prostatic tissue with glandular and stromal proliferation.
	- Benign urothelial mucosa with inflammation.		- Benign urothelial mucosa with inflammation.
	- ~~Negative~~ for malignancy.		- NEGATIVE for malignancy.
	</pre>		</pre>

Line 91:		Line 91:
	- Benign prostatic tissue.		- Benign prostatic tissue.
	- Benign urothelial mucosa with mild inflammation and calcification.		- Benign urothelial mucosa with mild inflammation and calcification.
	- ~~Negative~~ for malignancy.		- NEGATIVE for malignancy.
	</pre>		</pre>

Michael: /* Urothelium present */

2015-08-21T16:53:14Z

Urothelium present

← Older revision		Revision as of 16:53, 21 August 2015
Line 80:		Line 80:
	==Sign out==		==Sign out==
	===Urothelium present===		===Urothelium present===
			<pre>
			Prostate Tissue, Transurethral Resection of Prostate (TURP):
			- Benign prostatic tissue with glandular and stromal proliferation.
			- Benign urothelial mucosa with inflammation.
			- Negative for malignancy.
			</pre>

			<pre>
			Prostate Tissue, Transurethral Resection of Prostate (TURP):
			- Benign prostatic tissue.
			- Benign urothelial mucosa with mild inflammation and calcification.
			- Negative for malignancy.
			</pre>

			====Block letters====
	<pre>		<pre>
	PROSTATE TISSUE, TRANSURETHRAL RESECTION OF THE PROSTATE (TURP):		PROSTATE TISSUE, TRANSURETHRAL RESECTION OF THE PROSTATE (TURP):
Line 100:		Line 115:
	- UROTHELIUM WITH THE CHANGES OF CYSTITIS CYSTICA ET GLANDULARIS.		- UROTHELIUM WITH THE CHANGES OF CYSTITIS CYSTICA ET GLANDULARIS.
	- NEGATIVE FOR MALIGNANCY.		- NEGATIVE FOR MALIGNANCY.
	~~</pre>~~

	~~<pre>~~
	~~Prostate tissue, transurethral resection of prostate:~~
	~~- Benign prostatic tissue~~
	~~- Benign urothelial mucosa with mild inflammation and calcification~~
	~~- Negative for malignancy~~
	</pre>		</pre>

Michael at 03:21, 6 August 2015

2015-08-06T03:21:56Z

← Older revision		Revision as of 03:21, 6 August 2015
Line 7:		Line 7:
	\| Micro = stromal and/or glandular hyperplasia		\| Micro = stromal and/or glandular hyperplasia
	\| Subtypes =		\| Subtypes =
	\| LMDDx =		\| LMDDx = [[smooth muscle tumour of uncertain malignant potential]], subtle [[prostate carcinoma]]
	\| Stains =		\| Stains =
	\| IHC =		\| IHC =
Line 18:		Line 18:
	\| Assdx =		\| Assdx =
	\| Syndromes =		\| Syndromes =
	\| Clinicalhx =		\| Clinicalhx = old man
	\| Signs = hematuria, weak urine stream, incomplete urinary emptying, post-void dribbling, prolonged voiding, intermittency, hesitancy		\| Signs = hematuria, weak urine stream, incomplete urinary emptying, post-void dribbling, prolonged voiding, intermittency, hesitancy
	\| Symptoms = increased frequency of urination, straining		\| Symptoms = increased frequency of urination, straining
Line 28:		Line 28:
	\| Other =		\| Other =
	\| ClinDDx = other causes of hematuria ([[urothelial carcinoma]], [[renal cell carcinoma]], cystitis), other causes of obstruction ([[prostate carcinoma]], [[urothelial carcinoma]])		\| ClinDDx = other causes of hematuria ([[urothelial carcinoma]], [[renal cell carcinoma]], cystitis), other causes of obstruction ([[prostate carcinoma]], [[urothelial carcinoma]])
	\| Tx = medical, TURP		\| Tx = medical, [[TURP]]
	}}		}}
	'''Nodular hyperplasia of the prostate gland''', also '''benign prostatic hyperplasia''' (abbreviated '''BPH'''), is a common benign pathology of the [[prostate gland]].		'''Nodular hyperplasia of the prostate gland''', also '''benign prostatic hyperplasia''' (abbreviated '''BPH'''), is a common benign pathology of the [[prostate gland]].

Michael: /* Microscopic */

2015-08-06T03:20:38Z

Microscopic

← Older revision		Revision as of 03:20, 6 August 2015
Line 62:		Line 62:
	Features:		Features:
	*Stromal and/or glandular hyperplasia.		*Stromal and/or glandular hyperplasia.
			**Stromal component has small blood vessels.

	Notes:		Notes:

Michael: /* Microscopic */

2015-08-06T03:19:50Z

Microscopic

← Older revision		Revision as of 03:19, 6 August 2015
Line 70:		Line 70:
	*[[Urothelial carcinoma]] - significant nuclear atypia.		*[[Urothelial carcinoma]] - significant nuclear atypia.
	*[[Prostate carcinoma]] - especially low-grade.		*[[Prostate carcinoma]] - especially low-grade.
			*[[Smooth muscle tumour of uncertain malignant potential]] - lacks small vessels.<ref name=pmid17170745>{{Cite journal \| last1 = Hansel \| first1 = DE. \| last2 = Herawi \| first2 = M. \| last3 = Montgomery \| first3 = E. \| last4 = Epstein \| first4 = JI. \| title = Spindle cell lesions of the adult prostate. \| journal = Mod Pathol \| volume = 20 \| issue = 1 \| pages = 148-58 \| month = Jan \| year = 2007 \| doi = 10.1038/modpathol.3800676 \| PMID = 17170745 }}</ref>

	===Images===		===Images===

Michael: /* Microscopic */

2014-10-16T15:37:11Z

Microscopic

← Older revision		Revision as of 15:37, 16 October 2014
Line 65:		Line 65:
	Notes:		Notes:
	*Should '''not''' be diagnosed on core biopsy!		*Should '''not''' be diagnosed on core biopsy!
	*Cancer rates varies substaintially in resections done for BPH.		*One series suggests clinically relevant prostate cancer is seen in ~1.5% of resections for BPH.<ref>{{Cite journal \| last1 = Skrzypczyk \| first1 = MA. \| last2 = Dobruch \| first2 = J. \| last3 = Nyk \| first3 = L. \| last4 = Szostek \| first4 = P. \| last5 = Szempliński \| first5 = S. \| last6 = Borówka \| first6 = A. \| title = Should all specimens taken during surgical treatment of patients with benign prostatic hyperplasia be assessed by a pathologist? \| journal = Cent European J Urol \| volume = 67 \| issue = 3 \| pages = 227-32 \| month = \| year = 2014 \| doi = 10.5173/ceju.2014.03.art2 \| PMID = 25247076 }}</ref>
	**One series suggests clinically relevant prostate cancer is seen in ~1.5% of ~~cases~~.<ref>{{Cite journal \| last1 = Skrzypczyk \| first1 = MA. \| last2 = Dobruch \| first2 = J. \| last3 = Nyk \| first3 = L. \| last4 = Szostek \| first4 = P. \| last5 = Szempliński \| first5 = S. \| last6 = Borówka \| first6 = A. \| title = Should all specimens taken during surgical treatment of patients with benign prostatic hyperplasia be assessed by a pathologist? \| journal = Cent European J Urol \| volume = 67 \| issue = 3 \| pages = 227-32 \| month = \| year = 2014 \| doi = 10.5173/ceju.2014.03.art2 \| PMID = 25247076 }}</ref>

	DDx:		DDx: